Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 29:67:102531.
doi: 10.1016/j.amsu.2021.102531. eCollection 2021 Jul.

Clinical outcomes and costs of the use of fibrin sealant in pancreaticojejunal anastomosis after pancreaticoduodenectomy: a retrospective analysis study

Alberto Facury Gaspar  1 , Rafael Kemp  2 , Ajith Kumar Sankarankutty  2 , Jorge Resende Lopes Júnior  1 , João Almiro Ferreira Filho  1 , Daniel Martone  1 , Gustavo de Assis Mota  1 , José Sebastião Dos Santos  2
Affiliations

Clinical outcomes and costs of the use of fibrin sealant in pancreaticojejunal anastomosis after pancreaticoduodenectomy: a retrospective analysis study

Alberto Facury Gaspar et al. Ann Med Surg (Lond). .

Abstract

Objectives: The benefits of using a fibrin sealant to reinforce the pancreaticojejunal anastomosis are still contentious, a fact that justifies the study of its effects on clinical outcomes and costs of pancreaticoduodenectomy.

Methods: Study of 62 consecutive patients submitted to pancreaticoduodenectomy, divided into two groups of 31 patients each: GWS = group with sealant and GWOS = group without sealant that were compared according to demographic, clinical, laboratory aspects, the incidence of postoperative pancreatic fistula (POPF), according to the definition of the International Study Group on Pancreatic Fistula, updated in 2016, and its postoperative complications categorized according to the Clavien classification, as well as hospital costs evaluated by the absorption costing method (with the exception of those related to medications).

Results: The groups were homogeneous and there were no significant differences in the postoperative clinical course or in the indicators of hospital care between them. Hard texture of pancreatic tissue was the only protective factor against the development of POPF (RR = 0.29 (95%CI:0,12-0,68); p = 0.005). Moreover, hospital costs were higher in GWS than in GWOS (p < 0.0001).

Conclusions: The use of fibrin sealant to reinforce pancreaticojejunal anastomosis did not improve the clinical and healthcare outcomes and, in addition, increased hospital costs.

Keywords: Fibrin sealant; Healthcare costs; Pancreatic fistula; Pancreaticoduodenectomy.

PubMed Disclaimer

Conflict of interest statement

No conflicts of interest.

References

    1. Winter J.M., Cameron J.L., Campbell K.A. 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J. Gastrointest. Surg. 2006;10(9):1199–1210. - PubMed
    1. Fernández-Cruz L., Sabater L., Fabregat J. Complications after pancreaticoduodenectomy. Cir. Esp. 2012;90(4):222–232. - PubMed
    1. Pratt W.B., Maithel S.K., Vanounou T. Clinical and economic validation of the international study group of pancreatic fistula (ISGPF) classification scheme. Ann. Surg. 2007;245(3):443–451. - PMC - PubMed
    1. Gurusamy K.S., Koti R., Fusai G. Somatostatin analogues for pancreatic surgery. Cochrane Database Syst. Rev. 2012;6 - PubMed
    1. Yeo C.J., Cameron J.L., Lillemoe K.D. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial. Ann. Surg. 2000;232(3):419–429. - PMC - PubMed